| 1 |
Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome[J]. Nat Rev Dis Primers, 2019, 5(1): 18.
|
| 2 |
Matthay MA, McAuley DF, Ware LB. Clinical trials in acute respiratory distress syndrome: challenges and opportunities[J]. Lancet Respir Med, 2017, 5(6): 524-534.
|
| 3 |
Reilly JP, Christie JD, Meyer NJ. Fifty Years of Research in ARDS. Genomic Contributions and Opportunities[J]. Am J Respir Crit Care Med, 2017, 196(9): 1113-1121.
|
| 4 |
Cardinal-Fernandez P, Bajwa EK, Dominguez-Calvo A, et al. The presence of diffuse alveolar damage on open lung biopsy is associated with mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis[J]. Chest, 2016, 149(5): 1155-1164.
|
| 5 |
Park J, Lee YJ, Lee J, et al. Histopathologic heterogeneity of acute respiratory distress syndrome revealed by surgical lung biopsy and its clinical implications[J]. Korean J Intern Med, 2018, 33(3): 532-540.
|
| 6 |
Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment[J]. JAMA, 2018, 319(7): 698-710.
|
| 7 |
杨毅，邱海波. 急性呼吸窘迫综合征救治:需要遵循的十大原则[J/OL]. 中华重症医学电子杂志, 2015, 1(1): 33-38.
|
| 8 |
Hoelz C, Negri EM, Lichtenfels AJ, et al. Morphometric differences in pulmonary lesions in primary and secondary ARDS. A preliminary study in autopsies[J]. Pathol Res Pract, 2001, 197(8): 521-530.
|
| 9 |
Goodman LR, Fumagalli R, Tagliabue P, et al. Adult respiratory distress syndrome due to pulmonary and extrapulmonary causes: CT, clinical, and functional correlations[J]. Radiology, 1999, 213(2): 545-552.
|
| 10 |
Coppola S, Froio S, Marino A, et al. Respiratory mechanics, lung recruitability, and gas exchange in pulmonary and extrapulmonary acute respiratory distress syndrome[J]. Crit Care Med, 2019, 47(6): 792-799.
|
| 11 |
Calfee CS, Janz DR, Bernard GR, et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies[J]. Chest, 2015, 147(6): 1539-1548.
|
| 12 |
杨卿，李自强，蓝海兵, 等. 肺内源性和肺外源性急性呼吸窘迫综合征的生物标志物[J]. 中华医学杂志, 2017, 97(26): 2023-2027.
|
| 13 |
Gattinoni L, Pelosi P, Suter PM, et al. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?[J]. Am J Respir Crit Care Med, 1998, 158(1): 3-11.
|
| 14 |
Lim CM, Jung H, Koh Y, et al. Effect of alveolar recruitment maneuver in early acute respiratory distress syndrome according to antiderecruitment strategy, etiological category of diffuse lung injury, and body position of the patient[J]. Crit Care Med, 2003, 31(2): 411-418.
|
| 15 |
Pelosi P, Brazzi L, Gattinoni L. Prone position in acute respiratory distress syndrome[J]. Eur Respir J, 2002, 20(4): 1017-1028.
|
| 16 |
Sevransky JE, Martin GS, Shanholtz C, et al. Mortality in sepsis versus non-sepsis induced acute lung injury[J]. Crit Care, 2009, 13(5): R150.
|
| 17 |
Sheu CC, Gong MN, Zhai R, et al. Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS[J]. Chest, 2010, 138(3): 559-567.
|
| 18 |
Kangelaris KN, Prakash A, Liu KD, et al. Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS[J]. Am J Physiol Lung Cell Mol Physiol, 2015, 308(11): L1102-1113.
|
| 19 |
Calfee CS, Eisner MD, Ware LB, et al. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders[J]. Crit Care Med, 2007, 35(10): 2243-2250.
|
| 20 |
Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome[J]. N Engl J Med, 2010, 363(12): 1107-1116.
|
| 21 |
Guérin C, Reignier J, Richard JC, et al. Prone Positioning in Severe Acute Respiratory Distress Syndrome[J]. New England Journal of Medicine, 2013, 368(23): 2159-2168.
|
| 22 |
Briel M, Meade M, Mercat A, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis[J]. JAMA, 2010, 303(9): 865-873.
|
| 23 |
Croce MA, Fabian TC, Davis KA, et al. Early and late acute respiratory distress syndrome: two distinct clinical entities[J]. J Trauma, 1999, 46(3): 361-366; discussion 366-368.
|
| 24 |
Reilly JP, Bellamy S, Shashaty MG, et al. Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma[J]. Ann Am Thorac Soc, 2014, 11(5): 728-736.
|
| 25 |
Zhang R, Wang Z, Tejera P, et al. Late-onset moderate to severe acute respiratory distress syndrome is associated with shorter survival and higher mortality: a two-stage association study[J]. Intensive Care Med, 2017, 43(3): 399-407.
|
| 26 |
Puybasset L, Cluzel P, Chao N, et al. A computed tomography scan assessment of regional lung volume in acute lung injury. The CT Scan ARDS Study Group[J]. Am J Respir Crit Care Med, 1998, 158(5 Pt 1): 1644-1655.
|
| 27 |
Mrozek S, Jabaudon M, Jaber S, et al. Elevated Plasma Levels of sRAGE Are Associated With Nonfocal CT-Based Lung Imaging in Patients With ARDS: A Prospective Multicenter Study[J]. Chest, 2016, 150(5): 998-1007.
|
| 28 |
Puybasset L, Cluzel P, Gusman P, et al. Regional distribution of gas and tissue in acute respiratory distress syndrome. I. Consequences for lung morphology. CT Scan ARDS Study Group[J]. Intensive Care Med, 2000, 26(7): 857-869.
|
| 29 |
Rouby JJ, Puybasset L, Cluzel P, et al. Regional distribution of gas and tissue in acute respiratory distress syndrome. II. Physiological correlations and definition of an ARDS Severity Score. CT Scan ARDS Study Group[J]. Intensive Care Med, 2000, 26(8): 1046-1056.
|
| 30 |
Puybasset L, Gusman P, Muller JC, et al. Regional distribution of gas and tissue in acute respiratory distress syndrome. III. Consequences for the effects of positive end-expiratory pressure. CT Scan ARDS Study Group. Adult Respiratory Distress Syndrome[J]. Intensive Care Med, 2000, 26(9): 1215-1227.
|
| 31 |
Jabaudon M, Blondonnet R, Lutz J, et al. Net alveolar fluid clearance is associated with lung morphology phenotypes in acute respiratory distress syndrome[J]. Anaesth Crit Care Pain Med, 2016, 35(2): 81-86.
|
| 32 |
Gattinoni L, Caironi P, Cressoni M, et al. Lung recruitment in patients with the acute respiratory distress syndrome[J]. N Engl J Med, 2006, 354(17): 1775-1786.
|
| 33 |
Jabaudon M, Blondonnet R, Roszyk L, et al. Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome[J]. Am J Respir Crit Care Med, 2015, 192(2): 191-199.
|
| 34 |
Jabaudon M, Blondonnet R, Pereira B, et al. Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data[J]. Intensive Care Med, 2018, 44(9): 1388-1399.
|
| 35 |
Constantin JM, Jabaudon M, Lefrant JY, et al. Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial[J]. Lancet Respir Med, 2019, 7(10): 870-880.
|
| 36 |
Meyer NJ, Christie JD. Genetic heterogeneity and risk of acute respiratory distress syndrome[J]. Semin Respir Crit Care Med, 2013, 34(4): 459-474.
|
| 37 |
Tejera P, Meyer NJ, Chen F, et al. Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin[J]. J Med Genet, 2012, 49(11): 671-680.
|
| 38 |
Adamzik M, Frey U, Sixt S, et al. ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS[J]. Eur Respir J, 2007, 29(3): 482-488.
|
| 39 |
Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure[J]. Nature, 2005, 436(7047): 112-116.
|
| 40 |
Gu H, Xie Z, Li T, et al. Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus[J]. Sci Rep, 2016, 6(19840.
|
| 41 |
Zou Z, Yan Y, Shu Y, et al. Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections[J]. Nat Commun, 2014, 5: 3594.
|
| 42 |
Khan A, Benthin C, Zeno B, et al. A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome[J]. Crit Care, 2017, 21(1): 234.
|
| 43 |
Terpstra ML, Aman J, van Nieuw Amerongen GP, et al. Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis[J]. Crit Care Med, 2014, 42(3): 691-700.
|
| 44 |
傅萱，林锦乐，张文武, 等. ARDS生物标志物的研究进展[J]. 中华危重病急救医学, 2017, 29(7): 656-661.
|
| 45 |
Reilly JP, Wang F, Jones TK, et al. Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis[J]. Intensive Care Med, 2018, 44(11): 1849-1858.
|
| 46 |
Meyer NJ, Feng R, Li M, et al. IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist[J]. Am J Respir Crit Care Med, 2013, 187(9): 950-959.
|
| 47 |
Sapru A, Calfee CS, Liu KD, et al. Plasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome[J]. Intensive Care Med, 2015, 41(3): 470-478.
|
| 48 |
Proudfoot A, Bayliffe A, O′Kane CM, et al. Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury[J]. Thorax, 2018, 73(8): 723-730.
|
| 49 |
Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials[J]. Lancet Respir Med, 2014, 2(8): 611-620.
|
| 50 |
Delucchi K, Famous KR, Ware LB, et al. Stability of ARDS subphenotypes over time in two randomised controlled trials[J]. Thorax, 2018, 73(5): 439-445.
|
| 51 |
Famous KR, Delucchi K, Ware LB, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy[J]. Am J Respir Crit Care Med, 2017, 195(3): 331-338.
|
| 52 |
Sinha P, Delucchi KL, McAuley DF, et al. Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials[J]. Lancet Respir Med, 2020.
|
| 53 |
Calfee CS, Delucchi KL, Sinha P, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial[J]. Lancet Respir Med, 2018, 6(9): 691-698.
|
| 54 |
Sinha P, Delucchi KL, Thompson BT, et al. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study[J]. Intensive Care Med, 2018, 44(11): 1859-1869.
|
| 55 |
Bos LD, Schouten LR, van Vught LA, et al. Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis[J]. Thorax, 2017, 72(10): 876-883.
|
| 56 |
Bos LDJ, Scicluna BP, Ong DSY, et al. Understanding Heterogeneity in Biologic Phenotypes of Acute Respiratory Distress Syndrome by Leukocyte Expression Profiles[J]. Am J Respir Crit Care Med, 2019, 200(1): 42-50.
|